$Wild type transthyretin cardiac amiloidozis as a rare and overlooked underlying etiology in a patient with heart failure with preserved ejection fraction and left ventricular hypertrophy$
Código QR

Código QR

Wild type transthyretin cardiac amiloidozis as a rare and overlooked underlying etiology in a patient with heart failure with preserved ejection fraction and left ventricular hypertrophy

Guardado en:

Detalles Bibliográficos
Autores principales:	Selda Murat, Yüksel Çavuşoğlu, İlknur Ak Sivrikoz
Formato:	article
Lenguaje:	EN TR
Publicado:	KARE Publishing 2021
Materias:	Medicine R Internal medicine RC31-1245 Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/61c3c757fb7849c1a3255bfe3be20ce9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Left ventricular fibrosis and hypertrophy are associated with mortality in heart failure with preserved ejection fraction
por: Pankaj Garg, et al.
Publicado: (2021)

Correlation Between Liver Stiffness and Diastolic Function, Left Ventricular Hypertrophy, and Right Cardiac Function in Patients With Ejection Fraction Preserved Heart Failure
por: Junyi Zhang, et al.
Publicado: (2021)

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
por: Sebastiaan HC Klaassen, et al.
Publicado: (2020)

Effect of septal flash on right ventricular systolic function in left bundle-branch block patients with preserved left ventricular ejection fraction
por: Guang-yuan Li, et al.
Publicado: (2017)

The relationship between adiponectin and left ventricular mass index varies with the risk of left ventricular hypertrophy.
por: Yonggu Lee, et al.
Publicado: (2013)

Electrocardiographic left ventricular hypertrophy and outcome in hemodialysis patients.
por: Seung Jun Kim, et al.
Publicado: (2012)

Discrepancy between left ventricular hypertrophy by echocardiography and electrocardiographic hypertrophy: clinical characteristics and outcomes
por: Takao Kato, et al.
Publicado: (2021)

Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction
por: Arno A. van de Bovenkamp, et al.
Publicado: (2021)

Visual versus fully automated assessment of left ventricular ejection fraction
por: Rami Mahmood Abazid, et al.
Publicado: (2018)

The impact of obesity on left ventricular hypertrophy and diastolic dysfunction in children and adolescents
por: Joanna Bartkowiak, et al.
Publicado: (2021)

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
por: Alexander Grabner, et al.
Publicado: (2017)

Visceral fat level correction of the left ventricular hypertrophy electrocardiographic criteria
por: Szymon Salamaga, et al.
Publicado: (2021)

The etiology of cardiac hypertrophy in infants
por: Raymond Stegeman, et al.
Publicado: (2021)

Risk Factors And Epigenetic Markers Of Left Ventricular Diastolic Dysfunction With Preserved Ejection Fraction In A Community-Based Elderly Chinese Population
por: Wang W, et al.
Publicado: (2019)

Deep Learning Predicts Heart Failure With Preserved, Mid-Range, and Reduced Left Ventricular Ejection Fraction From Patient Clinical Profiles
por: Mohanad Alkhodari, et al.
Publicado: (2021)

Clinical course and outcomes of chronic heart failure with preserved left ventricular ejection fraction in concomitant overweight and obesity with comorbid atrial fibrillation
por: P. P. Bidzilya, et al.
Publicado: (2021)

Association between serum uric acid and left ventricular hypertrophy/left ventricular diastolic dysfunction in patients with chronic kidney disease.
por: Il Young Kim, et al.
Publicado: (2021)

Delayed repolarization and ventricular tachycardia in patients with heart failure and preserved ejection fraction.
por: Jae Hyung Cho, et al.
Publicado: (2021)

Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction
por: Ali Çoner, et al.
Publicado: (2021)

The Groningen electrocardiographic criteria for left ventricular hypertrophy: a sex-specific analysis
por: M. Yldau van der Ende, et al.
Publicado: (2021)

Consistency of left ventricular hypertrophy diagnosed by electrocardiography and echocardiography: the Northern Shanghai Study
por: Zhang W, et al.
Publicado: (2019)

Electrocardiographic left ventricular hypertrophy and mortality in an oldest-old hypertensive Chinese population
por: Chen R, et al.
Publicado: (2019)

Automated Measurements of Left Ventricular Ejection Fraction and Volumes Using the EchoPAC System
por: Xiaoxue Chen, MD, Shaoling Yang, PhD, Qianqian He, MD, Yin Wang, PhD, Linyan Fan, MD, Fengling Wang, MD, Kun Zhao, MD, Jing Hu, MD
Publicado: (2021)

Causes and predictors of hospital readmissions in patients older than 65 years hospitalized for heart failure with preserved left ventricular ejection fraction in western Romania
por: Mavrea AM, et al.
Publicado: (2015)

Left Ventricular Remodeling Risk Predicted by Two-Dimensional Speckle Tracking Echocardiography in Acute Myocardial Infarction Patients with Midrange or Preserved Ejection Fraction in Western Romania
por: Bordejevic DA, et al.
Publicado: (2021)

Clinical applicability and diagnostic performance of electrocardiographic criteria for left ventricular hypertrophy diagnosis in older adults
por: Caio de Assis Moura Tavares, et al.
Publicado: (2021)

Utility of Three Adiposity Indices for Identifying Left Ventricular Hypertrophy and Geometric Remodeling in Chinese Children
por: Huan Wang, et al.
Publicado: (2021)

Prevalence and associated factors of electrocardiographic left ventricular hypertrophy in a rural community, central Thailand
por: Patipan Viwatrangkul, et al.
Publicado: (2021)

Circulating level of miR-378 predicts left ventricular hypertrophy in patients with aortic stenosis.
por: Zhongxiu Chen, et al.
Publicado: (2014)

Dapagliflozin in the treatment of patients with heart failure with reduced left ventricular ejection fraction – a practical approach
por: Jadwiga Nessler
Publicado: (2021)

Left ventricular characteristics of noncompaction phenotype patients with good ejection fraction measured with cardiac magnetic resonance
por: Anna Reka Kiss, et al.
Publicado: (2021)

Usefulness of ECG criteria to rule out left ventricular hypertrophy in older individuals with true left bundle branch block: an observational study
por: Caio Assis Moura Tavares, et al.
Publicado: (2021)

Resting heart rate and real-life treatment modalities in outpatients with left ventricular systolic dysfunction study: A multicenter, prospective, observational, and national registry
por: Yüksel Çavuşoğlu1, et al.
Publicado: (2021)

Cardiac MRI structural and functional predictors of left ventricular ejection fraction recovery following PVC catheter ablation
por: Jessica Mao, et al.
Publicado: (2021)

Atherogenic index of plasma and left ventricular ejection fraction in newly diagnosed type 2 diabetes mellitus patients
por: Shaikat Mondal, et al.
Publicado: (2021)

The association of left ventricular hypertrophy with metabolic syndrome is dependent on body mass index in hypertensive overweight or obese patients.
por: Federico Guerra, et al.
Publicado: (2011)

Heart failure and preserved left ventricular function: long term clinical outcome.
por: Israel Gotsman, et al.
Publicado: (2012)

Hyperkalemia in chronic heart failure with renal dysfunction or diabetes mellitus: Results from the TREAT HF study
por: Selda Murat, et al.
Publicado: (2021)

External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure.
por: Mufaddal Mahesri, et al.
Publicado: (2021)

Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study
por: Ravi B. Patel, et al.
Publicado: (2021)